Page last updated: 2024-09-04
bz-423 and egtazic acid
bz-423 has been researched along with egtazic acid in 1 studies
Compound Research Comparison
| Studies (bz-423) | Trials (bz-423) | Recent Studies (post-2010) (bz-423) | Studies (egtazic acid) | Trials (egtazic acid) | Recent Studies (post-2010) (egtazic acid) |
|---|---|---|---|---|---|
| 56 | 0 | 14 | 10,021 | 11 | 686 |
Research
Studies (1)
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
Authors
| Authors | Studies |
|---|---|
| Bednarski, JJ; Boitano, AE; Glick, GD; Lyssiotis, CA; Opipari, AW; Roush, R | 1 |
Other Studies
1 other study(ies) available for bz-423 and egtazic acid
| Article | Year |
|---|---|
A novel benzodiazepine increases the sensitivity of B cells to receptor stimulation with synergistic effects on calcium signaling and apoptosis.
Topics: Animals; Apoptosis; B-Lymphocytes; Benzodiazepines; Calcium; Calcium Signaling; Cells, Cultured; Chelating Agents; Disease Models, Animal; Egtazic Acid; Female; Fluorescent Dyes; Germinal Center; Humans; Lupus Erythematosus, Systemic; Lymphocyte Activation; Mice; Mice, Inbred BALB C; Molecular Structure; Receptors, Antigen, B-Cell; Superoxides | 2004 |